Phenotypic evidence of emerging ivermectin resistance in Onchocerca volvulus
- PMID: 21468315
- PMCID: PMC3066159
- DOI: 10.1371/journal.pntd.0000998
Phenotypic evidence of emerging ivermectin resistance in Onchocerca volvulus
Abstract
Background: Ivermectin (IVM) has been used in Ghana for over two decades for onchocerciasis control. In recent years there have been reports of persistent microfilaridermias despite multiple treatments. This has necessitated a reexamination of its microfilaricidal and suppressive effects on reproduction in the adult female Onchocerca volvulus. In an initial study, we demonstrated the continued potent microfilaricidal effect of IVM. However, we also found communities in which the skin microfilarial repopulation rates at days 90 and 180 were much higher than expected. In this follow up study we have investigated the reproductive response of female worms to multiple treatments with IVM.
Methods and findings: The parasitological responses to IVM in two hundred and sixty-eight microfilaridermic subjects from nine communities that had received 10 to 19 annual doses of IVM treatment and one pre-study IVM-naïve community were followed. Skin snips were taken 364 days after the initial IVM treatment during the study to determine the microfilaria (mf) recovery rate. Nodules were excised and skin snips taken 90 days following a second study IVM treatment. Nodule and worm density and the reproductive status of female worms were determined. On the basis of skin mf repopulation and skin mf recovery rates we defined three categories of response--good, intermediate and poor--and also determined that approximately 25% of subjects in the study carried adult female worms that responded suboptimally to IVM. Stratification of the female worms by morphological age and microfilarial content showed that almost 90% of the worms were older or middle aged and that most of the mf were produced by the middle aged and older worms previously exposed to multiple treatments with little contribution from young worms derived from ongoing transmission.
Conclusions: The results confirm that in some communities adult female worms were non-responsive or resistant to the anti-fecundity effects of multiple treatments with IVM. A scheme of the varied responses of the adult female worm to multiple treatments is proposed.
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures
Similar articles
-
Reproductive status of Onchocerca volvulus after ivermectin treatment in an ivermectin-naïve and a frequently treated population from Cameroon.PLoS Negl Trop Dis. 2014 Apr 24;8(4):e2824. doi: 10.1371/journal.pntd.0002824. eCollection 2014 Apr. PLoS Negl Trop Dis. 2014. PMID: 24762816 Free PMC article.
-
An investigation of persistent microfilaridermias despite multiple treatments with ivermectin, in two onchocerciasis-endemic foci in Ghana.Ann Trop Med Parasitol. 2004 Apr;98(3):231-49. doi: 10.1179/000349804225003253. Ann Trop Med Parasitol. 2004. PMID: 15119969
-
Prevalence and intensity of Onchocerca volvulus infection and efficacy of ivermectin in endemic communities in Ghana: a two-phase epidemiological study.Lancet. 2007 Jun 16;369(9578):2021-2029. doi: 10.1016/S0140-6736(07)60942-8. Lancet. 2007. PMID: 17574093
-
Onchocerciasis control in Ghana (1974-2016).Parasit Vectors. 2021 Jan 2;14(1):3. doi: 10.1186/s13071-020-04507-2. Parasit Vectors. 2021. PMID: 33388081 Free PMC article. Review.
-
Recent updates on onchocerciasis: diagnosis and treatment.Clin Infect Dis. 2007 Jan 1;44(1):53-60. doi: 10.1086/509325. Epub 2006 Nov 29. Clin Infect Dis. 2007. PMID: 17143815 Review.
Cited by
-
Heartworm disease - Overview, intervention, and industry perspective.Int J Parasitol Drugs Drug Resist. 2021 Aug;16:65-89. doi: 10.1016/j.ijpddr.2021.03.004. Epub 2021 Apr 27. Int J Parasitol Drugs Drug Resist. 2021. PMID: 34030109 Free PMC article. Review.
-
Retarded Onchocerca volvulus L1 to L3 larval development in the Simulium damnosum vector after anti-wolbachial treatment of the human host.Parasit Vectors. 2012 Jan 11;5:12. doi: 10.1186/1756-3305-5-12. Parasit Vectors. 2012. PMID: 22236497 Free PMC article. Clinical Trial.
-
Clinical validation of molecular markers of macrocyclic lactone resistance in Dirofilaria immitis.Int J Parasitol Drugs Drug Resist. 2018 Dec;8(3):596-606. doi: 10.1016/j.ijpddr.2018.06.006. Epub 2018 Jul 18. Int J Parasitol Drugs Drug Resist. 2018. PMID: 30031685 Free PMC article.
-
Status of Onchocerciasis Elimination in Gabon and Challenges: A Systematic Review.Microorganisms. 2023 Jul 29;11(8):1946. doi: 10.3390/microorganisms11081946. Microorganisms. 2023. PMID: 37630506 Free PMC article. Review.
-
A Reevaluation of the Tolerability and Effects of Single-Dose Ivermectin Treatment on Onchocerca volvulus Microfilariae in the Skin and Eyes in Eastern Ghana.Am J Trop Med Hyg. 2021 Nov 29;106(2):740-745. doi: 10.4269/ajtmh.21-0859. Am J Trop Med Hyg. 2021. PMID: 34844204 Free PMC article.
References
-
- Duke BO, Zea-Flores G, Munoz B. The embryogenesis of Onchocerca volvulus over the first year after a single dose of ivermectin. Trop Med Parasitol. 1991;42:175–180. - PubMed
-
- World Health Organization. Geneva: WHO; 1995. Onchocerciasis and its control: Report of a WHO Expert Committee on Onchocerciasis Control. Technical Report Series No. 852. - PubMed
-
- Kläger S, Whitworth JA, Post RJ, Chavasse DC, Downham MD. How long do the effects of ivermectin on adult Onchocerca volvulus persist? Trop Med Parasitol. 1993;44:305–310. - PubMed
-
- Duke BOL, Zea-Flores G, Castro J, Cupp EW, Munoz B. Effect of multiple monthly doses of ivermectin on adult Onchocerca volvulus. Am J Trop Med Hyg. 1990;43:657–664. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources